Investigating the prostate specific antigen, body mass index and age relationship: is an age–BMI-adjusted PSA model clinically useful?
暂无分享,去创建一个
Jenny Donovan | Sean Harrison | Richard M Martin | Andrew Simpkin | Freddie C Hamdy | J Athene Lane | David E Neal | Kate Tilling | F. Hamdy | D. Neal | J. Donovan | K. Tilling | Richard M. Martin | J. Lane | Michael Davis | E. Turner | S. Harrison | A. Simpkin | Michael Davis | Emma L Turner | R. M. Martin | R. Martin | M. Davis
[1] David Chia,et al. Mortality results from a randomized prostate-cancer screening trial. , 2009, The New England journal of medicine.
[2] A. Neugut,et al. Modeling the effects of obesity and weight gain on PSA velocity , 2009, The Prostate.
[3] E. Steyerberg,et al. A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam. , 2013, European urology.
[4] C. Lindsell,et al. Relationship Between Prostate-specific Antigen, Age, and Body Mass Index in a Prostate Cancer Screening Population , 2012, American journal of clinical oncology.
[5] Jacques Ferlay,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .
[6] Prostate Cancer Can Be Detected Even in Patients with Decreased PSA Less than 2.5 ng/ml after Treatment of Chronic Prostatitis , 2011, Korean journal of urology.
[7] S. Iravani,et al. Opium Consumption Is Negatively Associated With Serum Prostate-Specific Antigen (PSA), Free PSA, and Percentage of Free PSA Levels , 2013, Journal of addiction medicine.
[8] A. Qureshi,et al. Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis. , 2012, American journal of epidemiology.
[9] Q. Mcnemar. Note on the sampling error of the difference between correlated proportions or percentages , 1947, Psychometrika.
[10] U B Seiffert,et al. Physical activity releases prostate-specific antigen (PSA) from the prostate gland into blood and increases serum PSA concentrations. , 1996, Clinical chemistry.
[11] W. Catalona,et al. Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies. , 2013, The Journal of urology.
[12] B. G. Blijenberg,et al. Prostate-cancer mortality at 11 years of follow-up. , 2012, The New England journal of medicine.
[13] W. Catalona,et al. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.
[14] V. Master,et al. Association between smoking status, and free, total and percent free prostate specific antigen. , 2012, The Journal of urology.
[15] Nicolas Barry Delongchamps,et al. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. , 2007, Journal of the National Cancer Institute.
[16] A. Actis,et al. Prostate-specific antigen: its relationship with alcohol intake and tobacco , 2012, Medical Oncology.
[17] R. Hayes,et al. Cancer Causes & Control , 2004, Cancer Causes & Control.
[18] F. Hamdy,et al. Very low PSA concentrations and deletions of the KLK3 gene. , 2013, Clinical chemistry.
[19] J. Stanford,et al. The effect of demographic and clinical factors on the relationship between BMI and PSA levels , 2011, The Prostate.
[20] I. Thompson,et al. Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening. , 2010, Urology.
[21] T. Peters,et al. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. , 2014, The Lancet. Oncology.
[22] M. Terris,et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. , 2007, JAMA.
[23] P. H. Petersen,et al. Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice. , 2005, Clinical chemistry.
[24] B. Kramer,et al. Screening for prostate cancer with PSA testing: current status and future directions. , 2011, Oncology.
[25] C. Mathers,et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .
[26] F. Hamdy,et al. Associations of Lifestyle Factors and Anthropometric Measures with Repeat PSA Levels During Active Surveillance/Monitoring , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[27] F. Montorsi,et al. Usefulness of prostate‐specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study , 2012, BJU international.
[28] D. Freedman,et al. Obesity Is Negatively Associated with Prostate-Specific Antigen in U.S. Men, 2001-2004 , 2007, Cancer Epidemiology Biomarkers & Prevention.
[29] H. Brenner,et al. Association of Diabetes and Body Mass Index with Levels of Prostate-Specific Antigen: Implications for Correction of Prostate-Specific Antigen Cutoff Values? , 2009, Cancer Epidemiology Biomarkers & Prevention.
[30] L. Ferrucci,et al. Should prostate specific antigen be adjusted for body mass index? Data from the Baltimore Longitudinal Study of Aging. , 2009, The Journal of urology.
[31] Douglas G Altman,et al. Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.
[32] Ziding Feng,et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. , 2006, Journal of the National Cancer Institute.
[33] Xiangyi Zheng,et al. Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis , 2011, Irish journal of medical science.
[34] F. Hamdy,et al. Association of diabetes mellitus with prostate cancer: Nested case–control study (Prostate testing for cancer and Treatment study) , 2011, International journal of cancer.
[35] S. Culp,et al. The effect of obesity and lower serum prostate‐specific antigen levels on prostate‐cancer screening results in American men , 2009, BJU international.
[36] V. Moyer,et al. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.
[37] B. G. Blijenberg,et al. Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.
[38] Ulleryd,et al. Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate‐specific antigen and transrectal ultrasonography , 1999, BJU international.
[39] V. Fontana,et al. Effect of Age, Family History of Prostate Cancer, Prostate Enlargement and Seasonality on PSA Levels in a Contemporary Cohort of Healthy Italian Subjects , 2011, The International journal of biological markers.
[40] Lei Xie,et al. Body mass index and risk of BPH: a meta-analysis , 2011, Prostate Cancer and Prostatic Diseases.
[41] M. Issa,et al. Evaluation of novel formula of PSA, age, prostate volume, and race in predicting positive prostate biopsy findings. , 2013, Urology.
[42] H. Klocker,et al. Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells. , 2011, Urology.
[43] W. Demark-Wahnefried,et al. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. , 2004, Urology.
[44] Carmen Rodriguez,et al. Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort , 2007, Cancer Epidemiology Biomarkers & Prevention.
[45] Xianglin L. Du,et al. Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population. , 2011, Central European journal of public health.
[46] H. Bartsch,et al. International Agency for Research on Cancer. , 1969, WHO chronicle.
[47] F. Hamdy,et al. Seasonal variation in prostate‐specific antigen levels: a large cross‐sectional study of men in the UK , 2011, BJU international.
[48] P. Walsh. The association of body mass index and prostate-specific antigen in a population-based study. , 2005, The Journal of urology.
[49] N. Hamajima,et al. ASSOCIATION OF OBESITY AND DIABETES WITH SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS IN JAPANESE MALES , 2012, Nagoya journal of medical science.
[50] J. Oesterling. Age-specific reference ranges for serum PSA. , 1996, The New England journal of medicine.
[51] L. Marignol,et al. Standardization of assay methods reduces variability of total PSA measurements: an Irish study , 2012, BJU international.